The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s neurodegenerative disorder therapeutics market report forecasts the neurodegenerative disorder therapeutics market size to grow to $23.65 Billion by 2027, with a CAGR (compound annual growth rate) of more than 8%.

Learn More On The Neurodegenerative Disorder Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurodegenerative Disorder Therapeutics Market Size Forecast

The global neurodegenerative disorder therapeutics market is expected to grow from $15.86 billion in 2022 to $17.14 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The neurodegenerative disorder therapeutics market is expected to grow from $23.65 billion in 2027 at a CAGR of 8.4%.

North America held the largest neurodegenerative disorder therapeutics market share, and North America was the fastest-growing region in 2022.

Key Neurodegenerative Disorder Therapeutics Market Driver ­– Increase In The Prevalence Of Neurodegenerative Among The Global Population

According to World Population Prospects, the number of people above 60 years of age will increase to 2.1 billion in 2050 and it is expected that people aged over 80 years will triple to 425 million in 2050. According to the Alzheimer’s Association, around 5.8 million Americans are suffering from Alzheimer’s disease, and this number is projected to rise to around 14 million by 2050. The increased prevalence of neurodegenerative diseases among the aging population increases the demand for neurodegenerative disorder therapeutics thereby driving the market.

Request for A Sample Of The Global Neurodegenerative Disorder Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2818&type=smp

Key Neurodegenerative Disorder Therapeutics Market Trend – Technological Advancement

Companies in the neurophysiology devices and equipment market are investing in the advancement of technology to increase the efficiency of these devices. There have been plenty of innovations in brain monitoring devices, for instance, EEG monitoring, Brain Simulation therapies, and Intraoperative Neurophysiological Monitoring. New technological innovations are enabling the development of devices that are integrating or adopting processes such as advanced neuroimaging techniques, stem cell therapies, molecular interventions, and microbiome technologies. There is also a trend of portable and wearable device technology assisting in home-based monitoring for ailments such as epilepsy and sleep apnea. For example, in March 2022, Braintale, a Paris-based developer of brain medication, launched brainTale-care platform. The platform is dedicated tto white matter quantification and brainScore-comaoffering that predicts coma.

Neurodegenerative Disorder Therapeutics Market Segment

1) By Technology: Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECoG), Evoked potential (EP)
2) By End Users: Hospitals, Ambulatory Surgical Centers
3) By Modality: Standalone, Portable

Neurodegenerative Disorder Therapeutics Market Major Players and Strategies

Major players in the neurodegenerative disorder therapeutics market are Medtronic PLC., Nihon Kohden Corporation, Dr. Langer Medical Gmbh, Natus Medical Incorporated, Inomed Medizintechnik, NuVasiveInc., Axon Healthcare Ltd., Bovie Medical Corporation, Neurosign, and Neurowave Systems.

The Neurodegenerative Disorder Therapeutics Global Market Report 2023 covers regional data on neurodegenerative disorder therapeutics market size, neurodegenerative disorder therapeutics market trends and drivers, opportunities, strategies, and neurodegenerative disorder therapeutics market competitor analysis. The countries covered in the neurodegenerative disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The neurophysiology devices and equipment deal with different functions of the nervous system such as spinal cord and peripheral nerve dysfunction brain alterations and nerve damage.

View More Reports Related To The Neurodegenerative Disorder Therapeutics Market –

Neurostimulation Devices Global Market Report 2023

Neurophysiology Devices And Equipment Global Market Report 2023

Neurosurgery Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: